Orchestra BioMed Holdings, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
OBIO on Nasdaq
Location
150 Union Square Drive, New Hope, PA

Insiders trading volume in the past year

Orchestra BioMed Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Medtronic plc 10%+ Owner $94.1M Dec 31, 2023
Roderick Wong Chief Executive Officer, Director, 10%+ Owner $45M Jan 24, 2023
Rtw Investments, Lp 10%+ Owner $34.8M +$10.3M +41.8% Aug 4, 2025
Geoffrey Wade Smith Director $24.3M Jul 20, 2023
Perceptive Advisors Llc 10%+ Owner $18.7M +$6.05M +47.9% Aug 1, 2025
HSAC 2 Holdings, LLC 10%+ Owner $8.78M Aug 5, 2024
David P. Hochman Chief Executive Officer and Chairperson, Director $2.6M +$113K +4.55% Sep 17, 2025
Darren Sherman President and Chief Operating Officer, Director $2.41M +$7.86K +0.33% Sep 3, 2025
William Reed Little Executive Vice President, Corporate Development & Strategy $2.16M May 30, 2024
Andrew Taylor Chief Financial Officer $1.15M +$9.93K +0.87% Sep 17, 2025
Michael Kaswan Chief Financial Officer $772K Apr 12, 2023
Yuval Mika General Manager and Chief Technology Officer, Bioelectronic Therapies $755K May 8, 2024
Jason Aryeh Director $266K +$2.45K +0.93% Sep 19, 2025
George Papandreou General Manager and Senior Vice President, Focal Therapies $200K May 8, 2024
Eric S. Fain Director $187K +$6.85K +3.8% Aug 25, 2025
Pamela Ann Connealy Director $129K Aug 7, 2025
David Pacitti Director $119K Aug 7, 2025
John Prosper Mack Director $107K Aug 7, 2025
Chris Cleary Director $99.6K Aug 7, 2025
Eric A. Md Rose Director $52.8K Jun 20, 2024
Joshua Aiello Principal Accounting Officer $47K Sep 17, 2025

Recent Insider Transactions by Companies or Individuals for Orchestra BioMed Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.